ImageneBio Inc beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.90 | $-0.63 | +30.0% | Beat |
| Q12026 FY2026 | $-0.70 | $-0.95 | -35.7% | Miss |
| Q12026 FY2026 | $-1.45 | — | — | Miss |
Back to IMA overview · IMA holders · IMA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.